Professional Communications, Apr 1, 2002 - Medical - 352 pages
Clinical application of antithrombotic therapy in both arterial disease (acute coronary syndromes, acute MI, peripheral arterial disease, valvular heart disease, atrial fibrillation) and venous disease (venous thromboembolic disease and pulmonary embolism). Results of major clinical trials and their implications for clinical practice are reviewed.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Role of Clotting Factors mm
Antithrombotic Thrombin Inhibitors
33 other sections not shown
abciximab acute coronary syndromes acute myocardial infarction alteplase angioplasty Ann Intern antibodies anticoagulant therapy antiplatelet therapy antithrombotic therapy aPTT artery disease aspirin atrial fibrillation bbreviations benefit bleeding blood bolus bypass Circulation clinical trials clopidogrel clotting coagulation coronary artery death deep vein thrombosis dose drug effect Engl enoxaparin eptifibatide factor V Leiden fibrinogen fibrinolytic fibrinolytic therapy Figure GPIIb/IIIa heart valve hemorrhage heparin high-risk hirudin increased infusion inhibitor intravenous ischemia ischemic Lancet LMWH low molecular weight mg bid molecular weight heparin monitoring mutation occlusion oral anticoagulant patency percutaneous coronary intervention placebo plasma platelet platelet activation platelet aggregation platelet inhibition prevention prosthetic protein prothrombin randomised randomized trial recurrent reduced reperfusion reteplase revascularization risk factors stent streptokinase stroke surgery Table Thromb Haemost thrombin Thrombolysis thrombophilia thrombotic thrombus ticlopidine tients tion tirofiban treatment unfractionated heparin unstable angina vascular disease venous thromboembolism venous thrombosis ventricular warfarin